DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,957,973 | +4.9% | 72,382 | +1.5% | 3.61% | +10.7% |
| Q2 2023 | $17,115,360 | -14.9% | 71,314 | -10.7% | 3.26% | -11.2% |
| Q1 2023 | $20,123,127 | -5.4% | 79,841 | -0.4% | 3.67% | -11.2% |
| Q4 2022 | $21,268,635 | +2.4% | 80,132 | -0.3% | 4.13% | -0.9% |
| Q3 2022 | $20,766,000 | +1.1% | 80,398 | -0.8% | 4.17% | +7.0% |
| Q2 2022 | $20,538,000 | -13.8% | 81,010 | -0.3% | 3.90% | +1.6% |
| Q1 2022 | $23,825,000 | -17.9% | 81,224 | -7.9% | 3.84% | -4.6% |
| Q4 2021 | $29,002,000 | +2.9% | 88,154 | -4.8% | 4.02% | -6.0% |
| Q3 2021 | $28,184,000 | +7.1% | 92,576 | -5.6% | 4.28% | +8.9% |
| Q2 2021 | $26,320,000 | +18.0% | 98,077 | -1.0% | 3.93% | +11.3% |
| Q1 2021 | $22,304,000 | +0.9% | 99,092 | -0.4% | 3.53% | -1.9% |
| Q4 2020 | $22,103,000 | -4.0% | 99,496 | -6.9% | 3.60% | -11.3% |
| Q3 2020 | $23,016,000 | +17.5% | 106,889 | -3.5% | 4.05% | +12.2% |
| Q2 2020 | $19,590,000 | +26.0% | 110,783 | -1.4% | 3.61% | +4.8% |
| Q1 2020 | $15,546,000 | -11.1% | 112,308 | -1.5% | 3.45% | +5.0% |
| Q4 2019 | $17,494,000 | +4.0% | 113,997 | -2.2% | 3.28% | -1.3% |
| Q3 2019 | $16,827,000 | -1.1% | 116,513 | -2.1% | 3.33% | -1.4% |
| Q2 2019 | $17,007,000 | +2.9% | 118,996 | -5.0% | 3.37% | +2.9% |
| Q1 2019 | $16,530,000 | +29.3% | 125,206 | +1.0% | 3.28% | +11.8% |
| Q4 2018 | $12,783,000 | -4.5% | 123,978 | +0.6% | 2.93% | +9.5% |
| Q3 2018 | $13,387,000 | +11.1% | 123,193 | +0.9% | 2.68% | +0.8% |
| Q2 2018 | $12,049,000 | +1.5% | 122,103 | +0.7% | 2.66% | +1.3% |
| Q1 2018 | $11,872,000 | +1.4% | 121,258 | -3.9% | 2.62% | +8.4% |
| Q4 2017 | $11,710,000 | +4.7% | 126,171 | -3.2% | 2.42% | +8.5% |
| Q3 2017 | $11,186,000 | +6.1% | 130,401 | +4.4% | 2.23% | +3.7% |
| Q2 2017 | $10,541,000 | +4.7% | 124,916 | +6.1% | 2.15% | +1.1% |
| Q1 2017 | $10,068,000 | +27.7% | 117,696 | +16.2% | 2.13% | +21.8% |
| Q4 2016 | $7,882,000 | +58.5% | 101,249 | +59.6% | 1.75% | +61.3% |
| Q3 2016 | $4,972,000 | +29.9% | 63,439 | +67.3% | 1.08% | +25.9% |
| Q2 2016 | $3,828,000 | +170.3% | 37,910 | +153.7% | 0.86% | +166.3% |
| Q1 2016 | $1,416,000 | +510.3% | 14,940 | +497.6% | 0.32% | +509.4% |
| Q4 2015 | $232,000 | +8.9% | 2,500 | 0.0% | 0.05% | -1.9% |
| Q3 2015 | $213,000 | -0.5% | 2,500 | 0.0% | 0.05% | +10.2% |
| Q2 2015 | $214,000 | +0.9% | 2,500 | 0.0% | 0.05% | +2.1% |
| Q1 2015 | $212,000 | -0.9% | 2,500 | 0.0% | 0.05% | -9.4% |
| Q4 2014 | $214,000 | +12.6% | 2,500 | 0.0% | 0.05% | -31.2% |
| Q3 2014 | $190,000 | -3.6% | 2,500 | 0.0% | 0.08% | 0.0% |
| Q2 2014 | $197,000 | – | 2,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |